TissueGene Inc (950160)

Currency in KRW
15,970
-310(-1.90%)
Closed·
Advertisement
950160 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
15,93016,420
52 wk Range
11,470149,000
Key Statistics
Bid/Ask
15,940.00 / 15,970.00
Prev. Close
16,280
Open
16,390
Day's Range
15,930-16,420
52 wk Range
11,470-149,000
Volume
406K
Average Volume (3m)
2.38M
1-Year Change
-64.5111%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
950160 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock price often moves in the opposite direction of the market

TissueGene Inc News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
30/07/2026
EPS / Forecast
584.60 / -60.00
Revenue / Forecast
819.27M / --
EPS Revisions
Last 90 days

Compare 950160 to Peers and Sector

Metrics to compare
950160
Peers
Sector
Relationship
P/E Ratio
−7.5x−7.7x−0.4x
PEG Ratio
0.08−0.050.00
Price/Book
6.6x2.6x2.6x
Price / LTM Sales
282.7x16.4x3.0x
Upside (Analyst Target)
-175.8%54.5%
Fair Value Upside
Unlock25.8%7.0%Unlock

Kolon TissueGene, Inc. develops cell therapies for orthopedic diseases and other unmet medical needs. The company’s lead product is the TG-C that has completed Phase II trials to treat osteoarthritis, as well as rheumatoid arthritis, meniscus, and spinal discs. It is also developing cell therapies for musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
547.63K0.13%8.70B
Other Institutional Investors
51.45M12.11%816.97B
Public Companies & Retail Investors
372.86M87.76%5.92T
Total
424.85M100.00%6.75T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Kolon Corporation9.46%40,171,365637,921,276
Kolon Life Science Inc.2.17%9,206,796146,203,920

People Also Watch

13,870
032820
+4.05%
205,500
036930
+0.74%
21,400
115180
-4.46%
8,080
046970
+15.10%

FAQ

What Is the TissueGene (KOSDAQ: 950160) Share Price Today?

The TissueGene stock price today is 15,970 KRW.

What Stock Exchange Does TissueGene (950160) Trade On?

TissueGene is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for TissueGene?

The stock symbol (also called a 'ticker') for TissueGene is "950160."

What Is the Current TissueGene Market Capitalisation?

As of today, TissueGene (KOSDAQ: 950160) market cap is 1.36T KRW.

What Is TissueGene's (950160) Earnings Per Share (TTM)?

The TissueGene EPS is currently -2,163 (Trailing Twelve Months).

Is 950160 a Buy or Sell From a Technical Analyst Perspective?

Based on today's TissueGene moving averages and other technical indicators, the daily buy/sell signal for 950160 stock is Strong Sell.

How Many Times Has TissueGene Stock Split?

TissueGene has split 0 times. (See the 950160 stock split history page for full effective split date and price information.)

What is the current trading status of TissueGene (KOSDAQ: 950160)?

As of 19/09/2026, TissueGene (950160) is trading at a share price of 15,970 KRW, with a previous close of 16,280 KRW. The stock has fluctuated within a day range of 15,930 KRW to 16,420 KRW, while its 52-week range spans from 11,470 KRW to 149,000 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.